Search Results for citation:"90 FR 13892"

Found 2 results

Search Results: citation:"90 FR 13892"

💰 Only
Oldest Newest
  • 2025-05163 — Thomas Andr'e Endicott, D.D.S.; Decision and Order
    Type:Notice
    Citation:90 FR 13892
    Reading Time:about 7 minutes

    The Drug Enforcement Administration (DEA) issued an order to revoke the registration of Dr. Thomas Andr'e Endicott, a dentist in Utah, due to his lack of authority to handle controlled substances after his state licenses were revoked. The DEA's decision is based on the fact that a practitioner must have state authority to dispense controlled substances to maintain DEA registration. Dr. Endicott did not respond to the order, which was served to him through various means, including email. Consequently, his DEA Certificate of Registration is revoked, and any pending registration applications he has are denied.

    Simple Explanation

    Dr. Thomas Endicott, a dentist in Utah, lost his permission to work with special medicines called "controlled substances" because his state licenses were taken away, and because of that, a government group called the DEA has taken away his permission card to use these medicines.

  • 2025-05279 — Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals
    Type:Notice
    Citation:90 FR 13892
    Reading Time:about a minute or two

    Royal Emerald Pharmaceuticals has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of controlled substances, specifically Marihuana (Cannabis), at their location in Desert Hot Springs, California. They intend to produce this substance to supply botanical raw materials and active pharmaceutical ingredients to researchers and manufacturers registered with the DEA. Individuals who wish to comment on or object to this application may do so electronically by May 27, 2025, through the Federal eRulemaking Portal. Written requests for a hearing regarding the application are also due by the same date.

    Simple Explanation

    Royal Emerald Pharmaceuticals wants to make special plant-based medicines, and they're asking for permission to do this from a big group called the DEA. People can tell the DEA what they think about this by sending a message before the end of May 2025.